These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32778769)

  • 1. CRMP2 is a therapeutic target that suppresses the aggressiveness of breast cancer cells by stabilizing RECK.
    Lin B; Li Y; Wang T; Qiu Y; Chen Z; Zhao K; Lu N
    Oncogene; 2020 Sep; 39(37):6024-6040. PubMed ID: 32778769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collapsin response mediator protein 2 is involved in regulating breast cancer progression.
    Shimada K; Ishikawa T; Nakamura F; Shimizu D; Chishima T; Ichikawa Y; Sasaki T; Endo I; Nagashima Y; Goshima Y
    Breast Cancer; 2014 Nov; 21(6):715-23. PubMed ID: 23381229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of CRMP2 phosphorylation repairs CNS by regulating neurotrophic and inhibitory responses.
    Nagai J; Owada K; Kitamura Y; Goshima Y; Ohshima T
    Exp Neurol; 2016 Mar; 277():283-295. PubMed ID: 26795088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRMP5 interacts with tubulin to inhibit neurite outgrowth, thereby modulating the function of CRMP2.
    Brot S; Rogemond V; Perrot V; Chounlamountri N; Auger C; Honnorat J; Moradi-Améli M
    J Neurosci; 2010 Aug; 30(32):10639-54. PubMed ID: 20702696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxiredoxin interaction with the cytoskeletal-regulatory protein CRMP2: Investigation of a putative redox relay.
    Pace PE; Peskin AV; Konigstorfer A; Jasoni CJ; Winterbourn CC; Hampton MB
    Free Radic Biol Med; 2018 Dec; 129():383-393. PubMed ID: 30315937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects on lung and bone metastasis of breast cancer by Wnt signalling inhibitor DKK1.
    Zhuang X; Zhang H; Li X; Li X; Cong M; Peng F; Yu J; Zhang X; Yang Q; Hu G
    Nat Cell Biol; 2017 Oct; 19(10):1274-1285. PubMed ID: 28892080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRMP2 as a Candidate Target to Interfere with Lung Cancer Cell Migration.
    Morales X; Peláez R; Garasa S; Ortiz de Solórzano C; Rouzaut A
    Biomolecules; 2021 Oct; 11(10):. PubMed ID: 34680167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphorylation of collapsin response mediator protein 2 on Tyr-479 regulates CXCL12-induced T lymphocyte migration.
    Varrin-Doyer M; Vincent P; Cavagna S; Auvergnon N; Noraz N; Rogemond V; Honnorat J; Moradi-Améli M; Giraudon P
    J Biol Chem; 2009 May; 284(19):13265-76. PubMed ID: 19276087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
    Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
    Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRD7 suppresses invasion and metastasis in breast cancer by negatively regulating YB1-induced epithelial-mesenchymal transition.
    Niu W; Luo Y; Zhou Y; Li M; Wu C; Duan Y; Wang H; Fan S; Li Z; Xiong W; Li X; Li G; Ren C; Li H; Zhou M
    J Exp Clin Cancer Res; 2020 Feb; 39(1):30. PubMed ID: 32028981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collapsin response mediator protein-2 (Crmp2) regulates trafficking by linking endocytic regulatory proteins to dynein motors.
    Rahajeng J; Giridharan SS; Naslavsky N; Caplan S
    J Biol Chem; 2010 Oct; 285(42):31918-22. PubMed ID: 20801876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
    Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
    Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic inhibition of CRMP2 phosphorylation at serine 522 promotes axonal regeneration after optic nerve injury.
    Kondo S; Takahashi K; Kinoshita Y; Nagai J; Wakatsuki S; Araki T; Goshima Y; Ohshima T
    Sci Rep; 2019 May; 9(1):7188. PubMed ID: 31076621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuning microtubule dynamics to enhance cancer therapy by modulating FER-mediated CRMP2 phosphorylation.
    Zheng Y; Sethi R; Mangala LS; Taylor C; Goldsmith J; Wang M; Masuda K; Carrami EM; Mannion D; Miranda F; Herrero-Gonzalez S; Hellner K; Chen F; Alsaadi A; Albukhari A; Fotso DC; Yau C; Jiang D; Pradeep S; Rodriguez-Aguayo C; Lopez-Berestein G; Knapp S; Gray NS; Campo L; Myers KA; Dhar S; Ferguson D; Bast RC; Sood AK; von Delft F; Ahmed AA
    Nat Commun; 2018 Feb; 9(1):476. PubMed ID: 29396402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer.
    Zhang J; Kong X; Li J; Luo Q; Li X; Shen L; Chen L; Fang L
    Oncol Rep; 2014 Mar; 31(3):1357-63. PubMed ID: 24366472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of the psychiatric risk gene Ankyrin 3 enhances microtubule dynamics through GSK3/CRMP2 signaling.
    Garza JC; Qi X; Gjeluci K; Leussis MP; Basu H; Reis SA; Zhao WN; Piguel NH; Penzes P; Haggarty SJ; Martens GJ; Poelmans G; Petryshen TL
    Transl Psychiatry; 2018 Jul; 8(1):135. PubMed ID: 30046097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of PIMREG promotes breast cancer aggressiveness via constitutive activation of NF-κB signaling.
    Jiang L; Ren L; Zhang X; Chen H; Chen X; Lin C; Wang L; Hou N; Pan J; Zhou Z; Huang H; Huang D; Yang J; Liang Y; Li J
    EBioMedicine; 2019 May; 43():188-200. PubMed ID: 30979686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The protein interactome of collapsin response mediator protein-2 (CRMP2/DPYSL2) reveals novel partner proteins in brain tissue.
    Martins-de-Souza D; Cassoli JS; Nascimento JM; Hensley K; Guest PC; Pinzon-Velasco AM; Turck CW
    Proteomics Clin Appl; 2015 Oct; 9(9-10):817-31. PubMed ID: 25921334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RECK is not an independent prognostic marker for breast cancer.
    Gomes LR; Fujita A; Mott JD; Soares FA; Labriola L; Sogayar MC
    BMC Cancer; 2015 Oct; 15():660. PubMed ID: 26449734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Insights into the Altering Function of CRMP2 by Phosphorylation.
    Sumi T; Imasaki T; Aoki M; Sakai N; Nitta E; Shirouzu M; Nitta R
    Cell Struct Funct; 2018; 43(1):15-23. PubMed ID: 29479005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.